Related Experiment Video
Updated: May 26, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Invasive fungal infections in renal transplant recipients
Parisa Badiee1, Abdolvahab Alborzi
1Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. dieep@yahoo.com
Abstract:
Invasive fungal infections are a significant and often lethal problem in transplant patients. Infections caused by geographically limited endemic fungi are infrequent, and Aspergillus species, Mucorales species, Candida species, and Cryptococcus neoformans are the opportunistic fungi responsible for most such infections. The symptoms of systemic fungal infections are nonspecific, particularly in their early stages. The high rates of mortality and graft loss owing to fungal infections render early diagnosis and treatment imperative in immunosuppressed patients. Current methods for the diagnosis of systemic fungal infections include imaging procedures, endoscopic methods and biopsies, microscopic and culture techniques, antibody and antigen-based serologic testing, and the detection (via polymerase chain reaction) of fungal deoxyribonucleic acid in blood or bronchoalveolar lavage fluid, as well as the careful analysis of signs and symptoms. Antifungal therapy should be initiated early in patients with a suspected fungal infection (even before laboratory findings have confirmed that diagnosis) and should be administered with appropriate adjustment of immunosuppressive regimens. To manage fungal infections in patients with renal failure, optimizing the pharmacokinetics of antifungal drugs to reduce the risk of nephrotoxicity is crucial.
Insights
Early diagnosis and treatment of invasive fungal infections are critical for transplant patients to prevent mortality and graft loss. Prompt antifungal therapy and adjusted immunosuppression are essential, especially in those with renal failure.
Area of Science:
- Medical Mycology
- Transplant Infectious Diseases
Background:
- Invasive fungal infections (IFIs) pose a significant lethal threat to transplant recipients.
- Opportunistic fungi like Aspergillus, Mucorales, Candida, and Cryptococcus cause most IFIs in this vulnerable population.
- Nonspecific early symptoms of IFIs complicate timely diagnosis and intervention.
Purpose of the Study:
- To highlight the imperative for early diagnosis and treatment of IFIs in immunosuppressed transplant patients.
- To review current diagnostic modalities for systemic fungal infections.
- To emphasize the importance of prompt antifungal therapy and immunosuppression adjustment.
Main Methods:
- Review of current diagnostic methods including imaging, endoscopy, microscopy, cultures, serologic testing, and molecular detection (PCR).
- Analysis of clinical signs and symptoms.
- Consideration of pharmacokinetic optimization for antifungal drugs in renal failure patients.
Main Results:
- IFIs are a major cause of mortality and graft loss in transplant recipients.
- A combination of diagnostic approaches is necessary for accurate and early detection.
- Early initiation of antifungal therapy, even before definitive diagnosis, is crucial.
Conclusions:
- Prompt diagnosis and treatment of IFIs are paramount in transplant patients to improve outcomes.
- Multimodal diagnostic strategies are essential for timely identification of fungal infections.
- Antifungal therapy and immunosuppression management must be tailored to individual patient needs, including renal function.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Fungal Phylum Microsporidia
